Home
About Us
About Us
Board of Directors
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Latest News
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
ASX Announcements
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
31-May-2022
GBM Agile opens to paxalisib in Europe
30-May-2022
Cleansing notice
25-May-2022
Application for quotation of securities - KZA
24-May-2022
Notification regarding unquoted securities - KZA
17-May-2022
Kazia marks DIPG Awareness Day
12-May-2022
Application for quotation of securities - KZA
11-May-2022
Cleansing notice
11-May-2022
Notification regarding unquoted securities - KZA
6-May-2022
Application for quotation of securities - KZA
5-May-2022
Update - Proposed issue of securities - KZA
Previous
1
2
3
4
5
Next
